Tags

Type your tag names separated by a space and hit enter

Nicardipine for Hypertension Following Aortic Coarctectomy or Superior Cavopulmonary Anastomosis.
World J Pediatr Congenit Heart Surg. 2016 Jan; 7(1):32-5.WJ

Abstract

BACKGROUND

Literature on the use of nicardipine, a dihydropyridine calcium channel antagonist, in children recovering from cardiac surgery is sparse and, to our knowledge, nonexistent in children with single ventricle anatomy. We aimed to report our experience with nicardipine in these patient populations.

METHODS

We performed a retrospective review of children recovering from aortic coarctectomy or superior cavopulmonary anastomoses who received nicardipine for hypertension at our institution between 2007 and 2013. Hemodynamic variables prior to and after nicardipine initiation were compared using paired t tests.

RESULTS

Seven children recovering from aortic coarctectomy (median age 8.6 months, range: 1.5 months-7.9 years) and four children recovering from superior cavopulmonary anastomosis (median age: seven months, range: five-nine months) were reviewed. For all patients, at six hours after initiation of nicardipine, mean systolic blood pressure was significantly decreased, 123 ± 19 versus 103 ± 14 mm Hg (P = .001), as were diastolic blood pressure, 68 ± 20 versus 53.5 ± 10 mm Hg (P = .041), and sodium nitroprusside dose, 4.3 ± 2.9 versus 1.3 ± 1.7 mcg/kg/min (P = .002). Further, within 24 hours, serum lactate decreased from 1.45 ± 0.82 to 0.81 ± 0.29 mg/dL (P = .016). Heart rate, blood urea nitrogen, and serum creatinine measurements were statistically unchanged.

CONCLUSIONS

Nicardipine effectively decreased blood pressure without apparent adverse events in a small cohort of children with postoperative hypertension while recovering from aortic coarctectomy or superior cavopulmonary anastomosis. Further research comparing nicardipine to more conventional titratable antihypertensive agents in these patient populations is warranted.

Authors+Show Affiliations

Division of Critical Care Medicine, Department of Pediatrics, Riley Hospital of Children, in affiliation with Indiana University, Indianapolis, IN, USA cmastrop@iupui.edu.Department of Pediatrics, Children's Hospital of Michigan, in affiliation with Wayne State University, Detroit, MI, USA.

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

26714991

Citation

Mastropietro, Christopher W., and Diego Arango Uribe. "Nicardipine for Hypertension Following Aortic Coarctectomy or Superior Cavopulmonary Anastomosis." World Journal for Pediatric & Congenital Heart Surgery, vol. 7, no. 1, 2016, pp. 32-5.
Mastropietro CW, Arango Uribe D. Nicardipine for Hypertension Following Aortic Coarctectomy or Superior Cavopulmonary Anastomosis. World J Pediatr Congenit Heart Surg. 2016;7(1):32-5.
Mastropietro, C. W., & Arango Uribe, D. (2016). Nicardipine for Hypertension Following Aortic Coarctectomy or Superior Cavopulmonary Anastomosis. World Journal for Pediatric & Congenital Heart Surgery, 7(1), 32-5. https://doi.org/10.1177/2150135115608815
Mastropietro CW, Arango Uribe D. Nicardipine for Hypertension Following Aortic Coarctectomy or Superior Cavopulmonary Anastomosis. World J Pediatr Congenit Heart Surg. 2016;7(1):32-5. PubMed PMID: 26714991.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Nicardipine for Hypertension Following Aortic Coarctectomy or Superior Cavopulmonary Anastomosis. AU - Mastropietro,Christopher W, AU - Arango Uribe,Diego, PY - 2015/12/31/entrez PY - 2015/12/31/pubmed PY - 2016/8/10/medline KW - cavopulmonary anastomosis KW - coarctation KW - hypertension KW - nicardipine KW - postoperative care SP - 32 EP - 5 JF - World journal for pediatric & congenital heart surgery JO - World J Pediatr Congenit Heart Surg VL - 7 IS - 1 N2 - BACKGROUND: Literature on the use of nicardipine, a dihydropyridine calcium channel antagonist, in children recovering from cardiac surgery is sparse and, to our knowledge, nonexistent in children with single ventricle anatomy. We aimed to report our experience with nicardipine in these patient populations. METHODS: We performed a retrospective review of children recovering from aortic coarctectomy or superior cavopulmonary anastomoses who received nicardipine for hypertension at our institution between 2007 and 2013. Hemodynamic variables prior to and after nicardipine initiation were compared using paired t tests. RESULTS: Seven children recovering from aortic coarctectomy (median age 8.6 months, range: 1.5 months-7.9 years) and four children recovering from superior cavopulmonary anastomosis (median age: seven months, range: five-nine months) were reviewed. For all patients, at six hours after initiation of nicardipine, mean systolic blood pressure was significantly decreased, 123 ± 19 versus 103 ± 14 mm Hg (P = .001), as were diastolic blood pressure, 68 ± 20 versus 53.5 ± 10 mm Hg (P = .041), and sodium nitroprusside dose, 4.3 ± 2.9 versus 1.3 ± 1.7 mcg/kg/min (P = .002). Further, within 24 hours, serum lactate decreased from 1.45 ± 0.82 to 0.81 ± 0.29 mg/dL (P = .016). Heart rate, blood urea nitrogen, and serum creatinine measurements were statistically unchanged. CONCLUSIONS: Nicardipine effectively decreased blood pressure without apparent adverse events in a small cohort of children with postoperative hypertension while recovering from aortic coarctectomy or superior cavopulmonary anastomosis. Further research comparing nicardipine to more conventional titratable antihypertensive agents in these patient populations is warranted. SN - 2150-136X UR - https://www.unboundmedicine.com/medline/citation/26714991/Nicardipine_for_Hypertension_Following_Aortic_Coarctectomy_or_Superior_Cavopulmonary_Anastomosis_ DB - PRIME DP - Unbound Medicine ER -